Pascal and Francis Bibliographic Databases

Help

Export

Selection :

Permanent link
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18348529

A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma

Author
HOYLES, Rachel K1 ; ELLIS, Ross W1 ; FOLEY, Noeleen M5 ; PEARSON, Stanley B6 ; EMERY, Paul6 ; VEALE, Douglas J6 ; DENTON, Christopher P7 ; WELLS, Athol U1 ; BLACK, Carol M7 ; DU BOIS, Roland M1 ; WELLSBURY, Jessica1 ; LEES, Belinda1 ; NEWLANDS, Pauline1 ; GOH, Nicole S. L1 ; ROBERTS, Christopher2 ; DESAI, Sujal3 ; HERRICK, Ariane L4 ; MCHUGH, Neil J5
[1] Royal Brompton Hospital, and Imperial College, London, United Kingdom
[2] University of Manchester, Manchester, United Kingdom
[3] Kings College Hospital, London, United Kingdom
[4] Hope Hospital, Salford, United Kingdom
[5] Royal National Hospital for Rheumatic Diseases, and Royal United Hospital, Bath, United Kingdom
[6] Leeds General Infirmary, Leeds, United Kingdom
[7] Royal Free Hospital, London, United Kingdom
Source

Arthritis and rheumatism. 2006, Vol 54, Num 12, pp 3962-3970, 9 p ; ref : 36 ref

CODEN
ARHEAW
ISSN
0004-3591
Scientific domain
Rheumatology
Publisher
Wiley, Hoboken , NJ
Publication country
United States
Document type
Article
Language
English
Keyword (fr)
Anticancéreux Azathioprine Corticostéroïde Cyclophosphamide Fibrose poumon Immunodépresseur Sclérodermie Traitement Voie intraveineuse Voie orale Agent alkylant Appareil respiratoire pathologie Immunopathologie Maladie autoimmune Maladie système Moutarde à l'azote Oxazaphosphinane dérivé Peau pathologie Poumon pathologie Tissu conjonctif pathologie
Keyword (en)
Antineoplastic agent Azathioprine Corticosteroid Cyclophosphamide Pulmonary fibrosis Immunosuppressive agent Scleroderma Treatment Intravenous administration Oral administration Alkylating agent Respiratory disease Immunopathology Autoimmune disease Systemic disease Nitrogen mustard Oxazaphosphinane derivatives Skin disease Lung disease Connective tissue disease
Keyword (es)
Anticanceroso Azatioprina Corticoesteroide Ciclofosfamida Fibrosis pulmonar Inmunodepresor Esclerodermia Tratamiento Vía intravenosa Vía oral Agente alquilante Aparato respiratorio patología Inmunopatología Enfermedad autoinmune Enfermedad sistémica Mostaza al nitrógeno Oxazafosfinano derivado Piel patología Pulmón patología Tejido conjuntivo patología
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02L Bones, joints and connective tissue. Antiinflammatory agents

Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B07 Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis

Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B11 Pneumology / 002B11D Respiratory system : syndromes and miscellaneous diseases

Discipline
Pharmacological treatments Pulmonology Sarcoidosis. Granulomatosis of undetermined origin. Connective tissue diseases. Vasculitides
Origin
Inist-CNRS
Database
PASCAL
INIST identifier
18348529

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web